Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trials

Set Alert for Clinical Trials

Myriad's GeneSight Psychotropic Genetic Test Improves Depression Therapy In Trial

Results of a randomized trial presented at the American Psychiatric Association conference show the GeneSight Psychotropic genetic test can improve the treatment of depression by identifying the medications most and least likely to be effective.

Personalized Medicine In Vitro Diagnostics Clinical Trials
Advertisement

Latest From Clinical Trials

QUOTED. May 18, 2018. William Abraham.

Results of a study showed that Impulse Dynamics' Optimizer device significantly improved exercise tolerance and quality of life in certain heart-failure patients. See what principal investigator (and cardiologist) William Abraham of Ohio State University said about those patients here.

Quoted Clinical Trials

HRS 2018: Optimizer Cardiac Contractility Device Helps Subset Of Heart-Failure Patients

The FIX-HF-5C trial, a subgroup study derived from the FIX-HF-5 pivotal trial, shows that the Impulse Dynamics Optimizer cardiac contractility modulation device significantly improved exercise tolerance and quality of life in certain heart-failure patients. Results of the trial were presented at the Heart Rhythm Society conference in Boston. Impulse Dynamics expects to file the final PMA module for US FDA for Optimizer in June.

Clinical Trials Approvals

iSTAR's Glaucoma Micro Device Shines In Early Follow-Up

iSTAR Medical reported six-month clinical trial data supporting its latest micro-invasive glaucoma surgery device, MINIject.

Ophthalmology Innovation

Starts & Stops: May 7-13, 2018

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made between May 7 and 13, 2018, including announcements from BioCardia, Akili Interactive Labs, Arch Therapeutics, and Acutus Medical.

Starts & Stops Clinical Trials

HRS 2018: CABANA Misses Endpoint, Leaving Questions About AF Ablation

The long-awaited results of the CABANA trial, a large randomized study comparing ablation to drug therapy as a first-line treatment for atrial fibrillation, were presented at the Heart Rhythm Society conference in Boston on May 10. The trial missed its primary endpoint in the "intent to treat" analysis, but showed a significant benefit for ablation in the "as-treated" analysis.

Cardiovascular Cardiology

Device Week, May 10, 2018 – Exoskeleton Report, BioTrinity Conference

On this week’s podcast, Marion Webb reports on emerging exoskeleton technology to help patients recovering from spinal cord injuries or stroke, and Catherine Longworth reports on BioTrinity 2018 in London, a gathering of investors and medtech innovators.

Device Week Clinical Trials

New NHS England Processes To Tackle Uncertainties And Delays In Setting Up Clinical Trial Sites

A new "standard charging methodology" is to be introduced across NHS England to allow drug and device clinical trials to get underway faster. Presently, there can be a difference of up to nine months between confirmations being issued by each NHS hospital taking part in a multi-site trial.

Clinical Trials Policy & Regulation

Starts & Stops: April 30-May 6, 2018

Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements made between April 30-May 7, 2018, including announcements from Biosense Webster, Endonovo Therapeutics, Intact Vascular, and NeoChord.

Starts & Stops Clinical Trials

QUOTED. May 1, 2018. John Schellhorn.

See what Global Kinetics Corporation CEO John Schellhorn told Medtech Insight about what the firm's wearable Parkinson's disease monitor brings to clinicians and patients after gaining multi-source funding for a randomized trial.

Innovation Clinical Trials
See All
UsernamePublicRestriction

Register